Your browser doesn't support javascript.
loading
Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study.
Willis, Connor; Bauer, Hillevi; Au, Trang H; Menon, Jyothi; Unni, Sudhir; Tran, Dao; Rivers, Zachary; Akerley, Wallace; Schabath, Matthew B; Badin, Firas; Sekhon, Ashley; Patel, Malini; Xia, Bing; Gustafson, Beth; Villano, John L; Thomas, John-Michael; Lubinga, Solomon J; Cantrell, Michael A; Brixner, Diana; Stenehjem, David.
Afiliación
  • Willis C; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Bauer H; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Au TH; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Menon J; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Unni S; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Tran D; Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN, USA.
  • Rivers Z; Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN, USA.
  • Akerley W; Department of Internal Medicine, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA.
  • Schabath MB; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Badin F; Department of Hematology and Oncology, Baptist Health Medical Group, Lexington, KY, USA.
  • Sekhon A; Department of Radiation Oncology, MetroHealth Medical Center, Cleveland, OH, USA.
  • Patel M; Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Xia B; Department of Medicine, Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Gustafson B; Precision Oncology Program, Saint Luke's Cancer Institute, Kansas City, MO, USA.
  • Villano JL; Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
  • Thomas JM; US Medical Oncology, Bristol Myers Squibb, Princeton, NJ, USA.
  • Lubinga SJ; Health Economics and Outcomes Research, Bristol Myers Squibb, Princeton, NJ, USA.
  • Cantrell MA; Global Medical Oncology, Bristol Myers Squibb, Princeton, NJ, USA.
  • Brixner D; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Stenehjem D; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
Oncotarget ; 13: 1306, 2022 Dec 06.
Article en En | MEDLINE | ID: mdl-36473137
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos